Cite
HARVARD Citation
Park, J. et al. (2017). Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise. Diabetes, obesity & metabolism. 19 (12), pp. 1681-1687. [Online].